Sustain

Sustain Therapeutics is an India-based biotechnology company focused on the development of sustained-release injectable formulations for the treatment of chronic diseases. The company utilizes a proprietary drug delivery platform to create long-acting versions of existing therapeutics, primarily targeting pain management and ophthalmology. Their lead programs are designed to provide localized, multi-week therapeutic relief from a single injection, significantly reducing the burden of frequent dosing for patients with conditions like osteoarthritis. By optimizing the pharmacokinetic profiles of established drugs, Sustain Therapeutics aims to improve patient compliance and clinical outcomes. The company's technology is particularly suited for applications where local delivery can minimize systemic side effects while maintaining therapeutic efficacy.